Modus Therapeutics Holding AB (OSTO:MODTX) 3-Year EBITDA Growth Rate : -35.20% (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Modus Therapeutics Holding AB 3-Year EBITDA Growth Rate?

Modus Therapeutics Holding AB's EBITDA per Share for the three months ended in Mar. 2024 was kr-0.09.

During the past 3 years, the average EBITDA Per Share Growth Rate was -35.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 5 years, the highest 3-Year average EBITDA Per Share Growth Rate of Modus Therapeutics Holding AB was 25.50% per year. The lowest was -35.20% per year. And the median was -4.85% per year.

Competitive Comparison of Modus Therapeutics Holding AB's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, Modus Therapeutics Holding AB's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Modus Therapeutics Holding AB's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Modus Therapeutics Holding AB's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Modus Therapeutics Holding AB's 3-Year EBITDA Growth Rate falls into.

Modus Therapeutics Holding AB 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Modus Therapeutics Holding AB (OSTO:MODTX) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Modus Therapeutics Holding AB 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Modus Therapeutics Holding AB's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Modus Therapeutics Holding AB (OSTO:MODTX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Modus Therapeutics Holding AB (OSTO:MODTX) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

Olof Palmes gata 29 IV, Stockholm, SWE, 11122

Website

https://www.modustx.com

Modus Therapeutics Holding AB is a Swedish clinical biotechnology company developing a treatment for sepsis and septic shock through the patented polysaccharide sevuparin. The drug candidate sevuparin has the opportunity to benefit patients and save large healthcare costs.

Modus Therapeutics Holding AB (OSTO:MODTX) Headlines

No Headlines